Journal article icon

Journal article

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: Outcomes in the Japanese subgroup of the VIEW 2 study

Abstract:

Background/aims To evaluate efficacy and safety of intravitreal aflibercept (IVT-AFL) in Japanese patients with wet age-related macular degeneration (wAMD) from the VIEW 2 trial. Methods In this double-masked study, patients were randomised to: 0.5 mg IVT-AFL every 4 weeks (0.5q4); 2 mg IVT-AFL every 4 weeks (2q4); 2 mg IVT-AFL every 8 weeks (2q8) after 3 monthly injections; or 0.5 mg ranibizumab every 4 weeks (Rq4). Main efficacy outcomes included vision maintenance and best-corrected visual...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1136/bjophthalmol-2014-305076

Authors


Expand authors...
Publisher:
BMJ Publishing Group Publisher's website
Journal:
British Journal of Ophthalmology Journal website
Volume:
99
Issue:
1
Pages:
Article: 92
Publication date:
2014-08-05
DOI:
EISSN:
1468-2079
ISSN:
0007-1161
URN:
uuid:459ff968-ae34-4c3e-a27f-d78ab7ea6b3d
Source identifiers:
481500
Local pid:
pubs:481500
Language:
English

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP